[1. Oellerich M., Amstrong VW. & Kahan B. et al. (1995) Lake Louise consensus conference on cyclosporin monitoring in organ transplantation: report of consensus panel, Ther Drug Monit. 17, 642-65410.1097/00007691-199512000-000178588235]Search in Google Scholar
[2. Kahan BD., Shaw LM. & Hold D. et al. (1990) Consensus document: Haw’s Cay meting on therapeutic drug monitoring of cyclosporine, Clin Chem. 36, 1510-6]Search in Google Scholar
[3. Levey AS., Coresh J., Greene T., Stevens LA., Zhang YL. & Hendriksen S., et al. (2006). Chronic Kidney Disease Epidemiology Collaboration. Using standardized serum creatinine values in the Modification of Diet in Renal Disease study equation for estimating glomerular filtration rate. Ann Intern Med. 145(4), 247-254.]Search in Google Scholar
[4. Miller WG. (2011). Glomerular Filtration Rate. The Importance of Standardized Serum Creatinine in Detecting Kidney Disease. ClinicalLaboratory News. 37(12), 10-12.]Search in Google Scholar
[5. Marqut P., Leger F., Pisano P. & Billaud EM. (2004). Suivi thérapeutique de la ciclosporineIn Suivi thérapeutique pharmacologique pourl’adaptation de posologie des médicaments, (pp 280-293). Paris: Elsevier]Search in Google Scholar
[6. Tedesco D. & Haragsim L. (2012). Cyclosporine: A Review, Journal of Transplantation, Article ID 230386, 7 pages. DOI:10.1155/2012/23038610.1155/2012/230386325947422263104]Search in Google Scholar
[7. Martins L., Ventura A. & Branco A. et al. (2004). Cyclosporine versus tacrolimus in kidney transplantation: are there differences in nephrotoxicity? Transplant Proc. 36(4), 877-879.10.1016/j.transproceed.2004.03.08315194300]Search in Google Scholar
[8. Ojo AO., Held P.J. & Port F.K. et al. (2003). Chronic renal failure after transplantation of a nonrenal organ. The New England Journal ofMedicine. 349(10), 931-940]Search in Google Scholar
[9. Ispas M., Chincisan C., Voidăzan S., Mărginean A. & Dobreanu M. (2012). Chronic kidney disease after treatment with cyclosporine or tacrolimus in heart transplant recipients - experience of a Romanian medical center. Revista Română deMedicină de Laborator. 20(2/4), 117-125]Search in Google Scholar
[10. Castel M.A., Farrero M., Vallejos I., Cardona M., Regueiro A. & Pérez-Villa F. (2011). Primary immunosuppression and outcome differences after heart transplantation: tacrolimus versus cyclosporine. Transplant Proc. 43(6), 2244-610.1016/j.transproceed.2011.06.05421839245]Search in Google Scholar
[11. Meiser B.M., Groetzner J. & Kaczmarek I. et al (2004). Tacrolimus or cyclosporine: which is the better partner for mycophenolate mofetil in heart transplant recipients? Transplantation. 78(4), 591-8.10.1097/01.TP.0000129814.52456.2515446320]Search in Google Scholar
[12 Baran D.A., Zucker M.J. & Arroyo L.H. et al. (2011). A prospective, randomized trial of singledrug versus dual-drug immunosuppression in heart transplantation: the tacrolimus in combination, tacrolimus alone compared (TICTAC) trial. Circ Heart Fail. 4(2), 129-3710.1161/CIRCHEARTFAILURE.110.95852021216835]Search in Google Scholar
[13. Kobashigawa J.A. (2011). Strategies in immunosuppression after heart transplantation: is less better? Circ Heart Fail. 4(2), 111-3]Search in Google Scholar
[14. Garlicki M. (2005). Post-transplant diabetes mellitus (PTDM) in heart recipients, AnnTransplant. 10(3), 51-3]Search in Google Scholar
[15. Simmonds J., Dewar C., Dawkins H., Burch M. & Fenton M. (2009). Tacrolimus in pediatric heart transplantation: ameliorated side effects in the steroid-free, statin era. Clin Transplant. 23(3), 415-41910.1111/j.1399-0012.2008.00934.x19537303]Search in Google Scholar
[16. Morales J.M., Andrés A. & Dominguez-Gil B. et al. (2005). Ten years of treatment with tacrolimus is related to an excellent renal function, allowing monotherapy in a large proportion of cases: unicentric results of the tacrolimus versus cyclosporine. A European multicentric study in kidney. Transplantation Proceedings. 37(9), 3738-3742]Search in Google Scholar